SHELDON STEPHEN (Chief Financial Officer) reported 1 transaction at KUVATRIS THERAPEUTICS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/23/2024ACC: 0001104659-24-027107
Officer· Chief Financial Officer
Since Aug 2022
-243.00
Net shares
Net seller
$160.14
Total sold
0
Open market trades
0B · 0S
1
Total transactions
243.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−243.00
Price / share
$0.66
Trade value
$160.14
% of position
1.8%
2/21/2024
13.74K→13.49K
Total
Net shares
−243.00
Net value
-$160.14
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/21/2024 | F · Tax Withholding | −243.00 | $0.66 | $160.14 | 1.8% | 13.74K | 13.49K |
| Total | −243.00 | -$160.14 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned1.11K
Total
1.11K indirect1.11K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 1.11K | Indirect |
| Total | 1.11K | 1.11K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported